Mizuho Securities USA LLC Acquires 10,757 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mizuho Securities USA LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 46.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 33,758 shares of the medical equipment provider's stock after purchasing an additional 10,757 shares during the period. Mizuho Securities USA LLC's holdings in Intuitive Surgical were worth $17,620,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the company. Atala Financial Inc purchased a new position in Intuitive Surgical during the fourth quarter worth about $25,000. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at approximately $26,000. BankPlus Trust Department acquired a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $28,000. Kohmann Bosshard Financial Services LLC purchased a new position in Intuitive Surgical in the 4th quarter valued at approximately $31,000. Finally, Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical during the fourth quarter worth $36,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 2.1 %

Intuitive Surgical stock traded down $10.78 during mid-day trading on Wednesday, reaching $509.03. The company's stock had a trading volume of 1,979,293 shares, compared to its average volume of 1,463,234. The firm has a market cap of $181.31 billion, a price-to-earnings ratio of 79.41, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The business has a 50 day moving average price of $561.24 and a 200-day moving average price of $532.59.

Remove Ads

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 11,545 shares of the firm's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares of the company's stock, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares of the company's stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 33,754 shares of company stock valued at $17,691,621. 0.90% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on ISRG. Raymond James boosted their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Royal Bank of Canada lifted their price objective on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Piper Sandler reissued an "overweight" rating and issued a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Truist Financial dropped their price objective on shares of Intuitive Surgical from $666.00 to $605.00 and set a "buy" rating for the company in a research note on Monday, March 17th. Finally, Bernstein Bank boosted their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average price target of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.